>
US Considering a Plan To Split Gaza into Two With One Zone Controlled by Israel and the Other...
WHO Drafts Plan For 'Global Health Emergency Corps' To Override Governments On Pandemics...
3.4 Million Foreign-Born People Claiming Welfare Benefits in Britain
Masked Muslim youths take to east London streets to 'defend our community' after police bann
Why 'Mirror Life' Is Causing Some Genetic Scientists To Freak Out
Retina e-paper promises screens 'visually indistinguishable from reality'
Scientists baffled as interstellar visitor appears to reverse thrust before vanishing behind the sun
Future of Satellite of Direct to Cellphone
Amazon goes nuclear with new modular reactor plant
China Is Making 800-Mile EV Batteries. Here's Why America Can't Have Them
China Innovates: Transforming Sand into Paper
Millions Of America's Teens Are Being Seduced By AI Chatbots
Transhumanist Scientists Create Embryos From Skin Cells And Sperm

3 patients experienced complete remission after regularly taking fenbendazole.
But the cancer industry seems to hate it because it only costs about $11 per week.
Fenbendazole (FBZ) is a medicine originally designed to treat worms and parasites in animals. Its sister drugs, Mebendazole and Albendazole, have had remarkable success treating similar ailments in humans with few side effects.
The case series highlights the remarkable stories of three cancer patients who achieved miraculous recoveries with fenbendazole after exhausting all conventional therapies.
After analyzing these cases, the abstract concluded, "FBZ appears to be a potentially safe and effective antineoplastic agent that can be repurposed for human use in treating genitourinary malignancies."
Adding to the growing evidence in support of fendendazole's use case against cancer, an Oklahoma man credited his miraculous cancer recovery to the pet med after overcoming terminal small cell lung cancer, defying a less than 1% survival rate and leaving doctors baffled.
This story is truly remarkable. Watch.